TBIO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Stats
Today's Volume	20 499.00
Average Volume	53 082.00
Market Cap	7.53M
EPS	$0 ( 2024-05-09 )
Next earnings date	( $-4.03 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.160
ATR14	$0.0420 (0.93%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Witney Frank	Buy	48 354	Common Stock
2023-07-06	Witney Frank	Buy	70 129	Stock Option (right to buy)
2023-07-06	Witney Frank	Buy	46 752	Common Stock
2024-05-01	Witney Frank	Buy	30 362	Stock Option (right to buy)
2024-05-01	Tumolo Annette	Buy	36 406	Common Stock

INSIDER POWER
97.56
Last 91 transactions
Buy: 77 090 763 \| Sell: 25 536 222

Volume Correlation

Long: 0.11 (neutral)

Short: 0.83 (strong)

Signal:(56.834) Same movement expected

Translate Bio Inc Correlation

10 Most Positive Correlations
RCM	0.931
BTF	0.915
AIHS	0.915
ICLR	0.913
ERIE	0.912
OSS	0.911
AHCO	0.909
ACVA	0.909
VKTX	0.906
GMII	0.905

10 Most Negative Correlations
DRNA	-0.948
SUMO	-0.941
OCSL	-0.925
SABR	-0.915
CMPI	-0.908
DPRO	-0.907
ALBO	-0.906
MIGI	-0.895
IMAQ	-0.893
TCBC	-0.892

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Translate Bio Inc Correlation - Currency/Commodity

-0.19
( neutral )

0.57
( weak )

0.00
( neutral )

-0.32
( neutral )

-0.64
( weak negative )

-0.26
( neutral )

Translate Bio Inc Financials

Annual	2023
Revenue:	$27.51M
Gross Profit:	$12.85M (46.70 %)
EPS:	$-1.600

FY	2023
Revenue:	$27.51M
Gross Profit:	$12.85M (46.70 %)
EPS:	$-1.600

FY	2022
Revenue:	$27.44M
Gross Profit:	$15.60M (56.84 %)
EPS:	$-1.650

FY	2020
Revenue:	$138.81M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.046

Financial Reports:

No articles found.

Translate Bio Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Translate Bio Inc

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.